Windlas Biotech Ltd

NSE: WINDLAS · BSE: 543329 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹1,028.00
Market cap: ₹2,158 Cr
Revenue (annual): ₹904.1 Cr
Net profit (annual): ₹66.44 Cr
P/E (TTM): 32.5×Sector 47.4×
Promoter holding: 63.31%+1.41% QoQ
FII holding: 2.04%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

14 Apr 2026 22:24 IST NSE

Windlas Biotech Board Meeting Outcome

Windlas Biotech Limited has scheduled a Board Meeting for April 17, 2026, to consider a proposal for the buyback of equity shares. Trading window for designated persons is closed from April 1, 2026, until 48 hours after the conclusion of the meeting.

Read the filing ↗